SEC Form 4 · accession 0001179110-18-007959
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fredric N Eshelman
Officer — Executive Chairman · Director
Period of report
May 31, 2018
Accepted (ET)
Jun 4, 2018 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 31, 2018 | A | 3,766 | $0.00 | A | 1,132,149 | D | |
| Common StockF2 | holding | — | — | — | 944,537 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F3 | $33.86 | May 31, 2018 | A | 14,141 | A | — | May 31, 2028 | Common Stock | 14,141 | 14,141 | D |
Explanation of responses
- F1The restricted stock award vests on May 31, 2019 and was made as part of and pursuant to Issuer's director compensation program.
- F2These shares of the Issuer's common stock are owned by Eshelman Ventures, LLC, an entity wholly owned by the reporting person.
- F3The option vests in one installment on May 31, 2019 and was made as part of and pursuant to the Issuer's director compensation program.